Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Genetic Markers for breast, ovarian, and prostatic cancer

Genetic Markers for breast, ovarian, and prostatic cancer

US Patent 6512091 · Granted Jan 28, 2003

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Biomarkers for predicting prostate cancer progression2025
Methods of treating PR-positive, luminal A breast cancer with PI3K inhibitor, pi2018
Methods and compositions for modulating estrogen receptor mutants2018
Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeut2016
Mutant selectivity and combinations of a phosphoinositide 3-kinase inhibitor com2015
SCDs as modifiers of the p53 pathway and methods of use2014
EEF2K as modifiers of the PTEN/AKT pathway and methods of use2014
Combinations of phosphoinositide 3-kinase inhibitor compounds chemotherapeutic a2013
Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeut2013
RORS as modifiers of the p21 pathway and methods of use2013
Methods and compositions for ameliorating the undesirable effects of chemotherap2012
MAP3Ks as modifiers of the p53 pathway and methods of use2012